These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 22494234)
1. Treatment of opioid dependence and cancer pain with sublingual buprenorphine: a case report. Park EM; Suzuki J Am J Addict; 2012; 21(3):283-4. PubMed ID: 22494234 [No Abstract] [Full Text] [Related]
10. Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine. Moody DE Expert Opin Drug Metab Toxicol; 2013 Jun; 9(6):675-97. PubMed ID: 23537174 [TBL] [Abstract][Full Text] [Related]
14. Another Senseless Death - The Case for Supervised Injection Facilities. Wakeman SE N Engl J Med; 2017 Mar; 376(11):1011-1013. PubMed ID: 28296603 [No Abstract] [Full Text] [Related]
15. Transdermal buprenorphine (Butrans) for chronic pain. Med Lett Drugs Ther; 2011 Apr; 53(1362):31-2. PubMed ID: 21502936 [TBL] [Abstract][Full Text] [Related]
16. [Buprenorphine as a new alternative for detoxification of heroin addicts. It causes only mild withdrawal problems, abating quickly]. Blennow G; Fergusson A; Medvedeo A Lakartidningen; 2000 Apr; 97(15):1830-3. PubMed ID: 10815411 [TBL] [Abstract][Full Text] [Related]
17. [Experience of using injectable formulation of buprenorphine for the detoxification treatment of heroin dependence patients]. Aso K Nihon Arukoru Yakubutsu Igakkai Zasshi; 2009 Jun; 44(3):156-66. PubMed ID: 19618840 [TBL] [Abstract][Full Text] [Related]
18. Treatment of cancer-related pain with transdermal buprenorphine: a report of three cases. Schriek P Support Care Cancer; 2004 Dec; 12(12):882-4. PubMed ID: 15480815 [TBL] [Abstract][Full Text] [Related]